TITLE
Cytogenetically normal acute myeloid leukemia_training set (HG-U133A)

SUMMARY
Analysis of mononuclear cells from bone marrow or peripheral blood from a training set of 163 adult patients with cytogenetically normal acute myeloid leukemia (CN-AML). Patients with CN-AML show heterogeneous treatment outcomes. Results provide insight into a prognostic gene signature for CN-AML.

ORGANISM
Homo sapiens

PLATFORM
GPL96 : [HG-U133A] Affymetrix Human Genome U133A Array

CITATIONS
Metzeler KH, Hummel M, Bloomfield CD, Spiekermann K et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood 2008 Nov 15;112(10):4193-201. PMID:Â  18716133

